NCT05600907View on ClinicalTrials.gov

Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

November 30, 2036

Study Completion Date

November 30, 2036

Conditions

Chronic Granulomatous DiseaseCGD

Interventions

BIOLOGICAL

JSP191

A monoclonal antibody that targets human CD117

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT05600907 - Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD) | Biotech Hunter | Biotech Hunter